Nova Mentis Life Science Corp.

Nova Mentis Life Science Corp.

Canadian securities regulators publish sixth review regarding women on boards and in executive officer positions

TORONTO, March 10, 2021 - Securities regulatory authorities in Alberta, Manitoba, New Brunswick, Nova Scotia, Ontario, Québec and Saskatchewan (the participating jurisdictions) today published results from the sixth year review of women on boards and in executive officer positions.The notice summarizes results from a review of the disclos... Read More...

BlackBerry AtHoc Introduces Derived Credentials and FedRAMP Authorization on AWS to Better Support U.S. Federal Government’s Cloud and Mobile Strategy

SAN RAMON, Calif., March 9, 2021 -- BlackBerry Limited (NYSE: BB; TSX: BB) today announced new technology advancements to BlackBerry® AtHoc that will improve how U.S. Federal agencies communicate and collaborate during times of crisis, and reduce the risk of unauthorized access to Federal data, systems and applications. BlackBerry AtHoc, ... Read More...

Media Advisory – Caisse de dépôt et placement du Québec — financial results for 2020

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Feb. 9, 2021 - Eclipse Gold Mining Corporation ("Eclipse") (TSXV: EGLD) (OTC: EGLPF) and Northern Vertex Mining Corp. ("Northern Vertex") (TSXV: NEE) (OTC-NASDAQ Intl: NHVCF) are pleased to announce that Eclipse has received ... Read More...

Nova Mentis Expands Pre-Clinical Development Pipeline; Company Begins Fragile X Syndrome Treatment with its Proprietary Psilocybin Drug

VANCOUVER, BC, Feb. 18, 2021 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a leader in the development of serotonergic psychedelic compounds, is pleased to announce that the Company is expanding its pre-clinical program to develop a novel diagnostic and treatment approach to fragile X s... Read More...

Eclipse Gold Receives Final Court Order Approving Plan of Arrangement with Northern Vertex and Announces Security Holder Voting Results

VANCOUVER, BC, Jan. 13, 2021 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that it has appointed Dr. Julia V. Perederiy, PhD to its Scientific Advisory Board, effective immediately.Nova Mentis Life Science Corp. (CNW Group/Nova Mentis Life Science Corp.)Specializing in early-stage ... Read More...

Nova Mentis Expands Psychedelic Drug Pipeline

VANCOUVER, BC, Dec. 29, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that it has added two additional psychedelic compounds to its drug portfolio. NOVA has contracted with its U.S. partner to begin manufacturing the active pharmaceutical ingredients (API), baeocystin and aeru... Read More...

Think Research Corporation Announces Grant of Equity Compensation and Appointment of Chief Operating Officer

TORONTO, Dec. 22, 2020 - Eastwood Capital Corp. (the "Acquiror") has today filed an early warning report (the "Early Warning Report") advising of its acquisition of an aggregate of 2,211,400 common shares (the "Shares") of Automotive Finco Corp. (the "Company") through a private transaction. The Shares were purchased at a price of $1.50 p... Read More...

Early Warning Report for Eastwood Capital Corp.

VANCOUVER, BC, Nov. 2, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that, further to its news release dated October 9, 2020, it has entered into a definitive amalgamation agreement, (the "Definitive Agreement") with Pilz Bioscience Corp. ("Pilz") and 1271642 B.C. Ltd. ("Nova ... Read More...

Historic Expansion of Agriculture Irrigation Infrastructure Reaches Financial Close

Investment will create jobs, expand agriculture production and grow the Alberta economyTORONTO, Dec. 21, 2020 - The Canada Infrastructure Bank (CIB), Alberta's government and eight irrigation districts have formalized an agreement for the Alberta Irrigation Project with the CIB investing $407.5 million.The Alberta government will contribu... Read More...

Canada and Ontario invest in green infrastructure to support residents of Pays Plat First Nation and Biigtigong Nishnaabeg First Nation

VANCOUVER, BC, Dec. 3, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that it has appointed Dr. Marvin S. Hausman, MD as Chairman of its Scientific Advisory Board, effective immediately. Dr. Hausman is the Chief Medical Officer of Pilz Bioscience Corp., a wholly-owned subsidiar... Read More...

Nova Mentis Appoints Dr. Marvin S. Hausman as Chairman of Scientific Advisory Board

VANCOUVER, BC, Dec. 3, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that it has appointed Dr. Marvin S. Hausman, MD as Chairman of its Scientific Advisory Board, effective immediately. Dr. Hausman is the Chief Medical Officer of Pilz Bioscience Corp., a wholly-owned subsidiar... Read More...

Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Provides Corporate Update

VANCOUVER, BC, Nov. 11, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that its pending acquisition target, Pilz Bioscience Corp. ("Pilz"), has provided a corporate update.Dr. Marvin S. Hausman MD, Chairman and Chief Scientific Officer of Pilz commented: "We are very pleased wi... Read More...

Nova Mentis Life Science Acquisition Target, Pilz Bioscience Corp, Signs Psilocybin Manufacturing Agreement

VANCOUVER, BC, Nov. 5, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that its pending acquisition target, Pilz Bioscience Corp. ("Pilz"), has entered into a psilocybin manufacturing agreement with a U.S. based pharmaceutical company with over 800 employees. Pilz will have comp... Read More...

Nova Mentis Life Science Signs Amalgamation Agreement to Acquire 100% of Pilz BioScience Corp.

VANCOUVER, BC, Nov. 2, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that, further to its news release dated October 9, 2020, it has entered into a definitive amalgamation agreement, (the "Definitive Agreement") with Pilz Bioscience Corp. ("Pilz") and 1271642 B.C. Ltd. ("Nova ... Read More...